Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Botulinum toxin type B
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Botulinum toxin type B 10,000units/2ml inj vials
0409030A0AAACAC
|
Botulinum toxin type B | Botulinum toxin type B | Central Nervous System | No data available |
|
Botulinum toxin type B 2,500units/0.5ml inj vials
0409030A0AAAAAA
|
Botulinum toxin type B | Botulinum toxin type B | Central Nervous System | No data available |
|
Botulinum toxin type B 5,000units/1ml inj vials
0409030A0AAABAB
|
Botulinum toxin type B | Botulinum toxin type B | Central Nervous System | No data available |
|
Myobloc 10,000units/2ml solution for injection vials
0409030A0BCACAC
|
Myobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
Myobloc 2,500units/0.5ml solution for injection vials
0409030A0BCAAAA
|
Myobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
Myobloc 5,000units/1ml solution for injection vials
0409030A0BCABAB
|
Myobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
NeuroBloc 10,000units/2ml solution for injection vials
0409030A0BBACAC
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
NeuroBloc 2,500units/0.5ml solution for injection vials
0409030A0BBAAAA
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
|
NeuroBloc 5,000units/1ml solution for injection vials
0409030A0BBABAB
|
Neurobloc | Botulinum toxin type B | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.